早筛的冰与火:雅培210亿美元吞下Exact Sciences,中国同行何以半壁凋零

华夏时报网
Nov 28

近日,2025年全球医疗领域最大收购案官宣,雅培210亿美元吞下早筛龙头。  据悉,跨国医疗巨头雅培宣布以210亿美元(约合人民币1493亿元)全现金收购癌症早筛公司Exact Sciences,以进军不断增长的多癌种早期检测市场。而这家总部位于美国威斯康星州的分子诊断公司,凭借其明星产品Cologuard——一款无创结直肠癌筛查测试,已成为美国癌症早筛市场的标杆企业。  值得注意的是,这笔交易...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10